Recurrence of ventricular fibrillation in a patient with non-type 1 Brugada electrocardiographic morphology  by Tagawa, Minoru et al.
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s  u  m  m  a  r  y
A  healthy  25-year-old  man  suffered  from  loss  of  consciousness  due  to ventricular  ﬁbrillation  (VF).
Emergency services  required  multiple  cardioversion  to restore  sinus  rhythm.  Repeated  electrocardio-ccepted 14 March 2012
eywords:
entricular ﬁbrillation
on-type  1 ST-segment elevation
graphic (ECG)  recordings  after  admission  showed  non-type  1 Brugada  ST-segment  elevation  in V1  and
V2. Intravenous  pilsicainide  infusion  augmented  the ST-segment  elevation  but  its morphology  did  not
represent type-1  ECG.  Intravenous  administration  of  isoproterenol  normalized  the  ST-segment  elevation,
and programmed  electrical  stimulation  induced  VF.  Spontaneous  VF recurred  1 year after  introduction
of implantable  cardioverter  deﬁbrillator.  Non-type  1  ST-segment  elevation,  to  which  pharmacological
responses are  similar  to  Brugada  syndrome,  may  be  used  as a hallmark  of ventricular  tachyarrhythmia.
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Type 1 electrocardiographic (ECG) morphology (coved-type),
hich is either observed spontaneously or induced by class I antiar-
hythmic drugs, is considered to be a diagnostic sign of Brugada
yndrome [1]. Here, we report a patient who was  rescued from
borted  sudden cardiac death due to ventricular ﬁbrillation (VF).
epetitive ECG recordings showed day-to-day variation of the ST-
egment  elevation but none of them revealed type 1 ST-segment
levation. However, pharmacological interventions using pilsi-
ainide  and isoproterenol (ISP) showed similar responses to those
bserved in Brugada syndrome [1,2]. Spontaneous VF recurred 1
ear after the introduction of an implantable cardioverter deﬁbril-
ator.
ase  reportA  healthy 25-year-old man  suddenly fell unconscious due to
F  in the early morning, and his father immediately started cardiac
esuscitation.  The VF was terminated by 150 J biphasic shocks in the
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mbulance. In the hospital, his vital signs gradually recovered with-
ut  any neurological complications. He did not have any episodes
f  syncope or history of cardiovascular disease. There was  no family
istory  of sudden death. A chest radiograph and two-dimensional
chocardiogram were normal. Results of hematological and sero-
ogical examinations after complete recovery of his consciousness
ere  in the normal range.
His ECG upon admission showed normal sinus rhythm and nei-
her  ST-segment deviation nor J waves were observed (Fig. 1).
owever,  mild non-type 1 ST-segment elevations (1–2 mm)  with
 day-to-day and throughout-the-day variation were noted in
eads of V1 and V2 after the admission (Fig. 1). Only non-type 1
T-segment  elevation was  recorded at the 3rd rib precordial posi-
ion. The late potential was  positive in a signal-averaged ECG:
RS  duration = 137 ms,  LAS40 = 50 ms  and RMS40 = 6.2 V. We  sus-
ected  that the patient was  in Brugada syndrome and ISP infusion
1  g/min) was  started. The ST-segment elevation in lead V1 and V2
as normalized, and neither ST-segment elevation nor VF recurred
or  the next 10 days while undergoing continuous ISP infusion.
After  obtaining informed consent from him and his parents,
tandard cardiac catheterization and electrophysiological study
ere  performed 6 h after cessation of the ISP infusion. Intrac-
rdiac  pressure study and the left ventriculogram were normal,
nd  coronary angiogram did not show any stenotic segments.
oronary vasospasm was not induced by intracoronary injection
f  ergonovine maleate. Sinus node function and atrioventriular
vier Ltd. All rights reserved.
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digure 1. Electrocardiographic recordings after admission. (A) There was  no app
ariation (a and b) was noted in leads V1 and V2. (C) Non-type 1 ST-segment elevat
onduction were normal. During sinus rhythm, his HV interval pro-
onged to 65 ms.  VF was induced by triple extrastimulation from the
utﬂow tract of the right ventricle. The VF was not terminated by a
iphasic external shock of 150 J, and an additional 200 J shock was
equired to resume sinus rhythm. Monomorphic ventricular tachy-
ardia was not induced by the programmed electrical stimulation.
The  patient weighed 88 kg and we planned to administrate
8 mg  (1 mg/kg) of pilsicainide. However, ST-T elevation > 5 mm
as  noted in V2 and V3, and the drug administration was  stopped
 min  after starting the infusion (the total amount of pilsicainide
iven  was 70 mg). Pilsicainide manifested non-type 1 ST-segment
levation  with a beat-to-beat variation, but type 1 ST-segment
levation and/or J wave augmentation was not recorded on the
CGs  from standard and 3rd rib precordial position (Fig. 2). The
T-segment  elevation was normalized by ISP infusion. Neither ven-
ricular tachyarrhythmia nor ST-segment alteration was induced
y  treadmill exercise test. Genetic analysis of SCN5A was nega-
ive.  Because of lack of the type-1 ECG morphology, we could not
iagnose the patient as having Brugada syndrome.
The patient agreed with the treatment of an implantable car-
ioverter  deﬁbrillator (ICD) (ATLAS+ VR, St. Jude Medical, St Paul,
N,  USA), and one year later, recurrent VF was successfully termi-
ated  by ICD.
iscussion
A  type 1 ECG is characterized by a coved ST-segment eleva-
ion  ≥ 2 mm followed by a negative T wave [1]. However, in a recent
tudy  of Japanese patients with Brugada-type ECG, Kamakura et al.
eported that the incidence of fatal arrhythmia was similar between
he  patients with type 1 ECG and the patients with non-type 1
CG  [3]. In both of the ECG morphologies (type 1 and non-type 1
T-segment elevation), the patients resuscitated from VF showed
 signiﬁcantly worse prognosis than the patients with syncope
i
t
m
hST-T deviation upon admission. (B) Mild ST-segment elevation with day-by-day
as recorded at the 3rd rib precordial position.
pisodes  or the patients with no clinical symptoms [3]. Take et al.
eported that day-to-day or throughout-the-day alteration of the
T-segment elevation was more frequently observed in the patients
ith  (rather than the patients without) a history of VF in Bru-
ada  syndrome [4]. Furthermore, using an experimental model
f  Brugada syndrome, they demonstrated that such ECG alter-
ation  was  caused by repolarization instability especially in the
picardial myocardium and this could facilitate the initiation of
hase 2 re-entry and VF [4]. They also reported that coved ST-
egment  elevation (>2 mm)  with a shallow or absent negative T
ave  (it was called type 0 morphology in their report) was  observed
efore  initiation of VF and this ECG morphology implied the exis-
ence  of loss-of-dome shaped action potentials in the epicardial
yocardium. We  think that our case belongs in the non-type 1
CG patients and his ECG observed at pilsicainide test resem-
les  type 0 morphology in Take’s study. Therefore, he seemed
o  have both clinical (history of sudden cardiac death) and ECG
haracteristics (spontaneous alteration of ST-segment elevation
nd  manifestation of type 0 ECG morphology during pilsicainide
est)  that were comparable to the high-risk patients in the stud-
es  of Kamakura and Take [3,4]. In addition, macroscopic T-wave
lternation,  which was  observed after administering pilsicainide,
s  thought to reﬂect the vulnerability of ventricular repolarization,
nd  this phenomenon may  indicate relatively high arrhythmogenic
otential in this patient [5].
Recent studies demonstrated that VF can occur in patients
ith no apparent structural diseases (idiopathic VF), and several
ypes  of cardiovascular diseases are included in the category of
diopathic VF; Brugada syndrome, J-wave associated idiopathic VF,
atecholamine-sensitive polymorphic VT, or long or short QT  syn-
rome, etc. [6–8]. In our case, J wave was  not obvious and QT
nterval  was  normal in all of his ECG recordings. Exercise test of
readmill  and ISP infusion did not induce ventricular tachyarrhyth-
ias.  Therefore, although type 1 ECG has not been demonstrated,
is  clinical and ECG characteristics were closest to those of patients
M. Tagawa et al. / Journal of Cardiology Cases 6 (2012) e17–e19 e19
F fusio
b  eleva
n
w
n
a
o
n
(
a
w
i
s
R
[
[
[
[
[
[
[
[igure 2. Electrocardiograhic (ECG) recordings during pilsicainide testing and ISP in
y  the administration of pilsicainide but the ECG did not show type 1 ST-segment
ormalized  (C).
ith Brugada syndrome [1,2,9]. Different from the patients diag-
osed  as clearly having Brugada syndrome, clinical characteristics
nd  prognosis of the patients showing Brugada-like ECG (like
ur  case) have not yet been fully clariﬁed. Furthermore, sponta-
eous  alteration of the ST-segment may  be mild in some patients
<1–2  mm alteration in our case). Therefore, in order to reach an
ppropriate  diagnosis and select a reasonable therapeutic strategy,
e  need to pay attention to the possible ECG alteration especially
n  patients with no apparent heart diseases but a history of aborted
udden  cardiac death (or loss of consciousness).
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